The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial.
Jiang XY, Gong MQ, Zhang HJ, Peng AQ, Xie Z, Sun D, Liu L, Zhou SQ, Chen H, Yang XF, Song JF, Yu B, Jiang Q, Ma X, Gu J, Yang F, Zeng H, Zou QM.
Jiang XY, et al. Among authors: liu l.
Vaccine. 2023 Aug 31;41(38):5562-5571. doi: 10.1016/j.vaccine.2023.07.047. Epub 2023 Jul 27.
Vaccine. 2023.
PMID: 37516573
Clinical Trial.
METHODS: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial was carried out in 10 clinical research centers in China. Patients undergoing elective surgery for closed fractures, aged 18-70 years, were randomly allocated at a ratio of 1:1 to r …
METHODS: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial was carried out in 10 clinical research centers …
